...
首页> 外文期刊>European journal of pharmaceutical sciences >Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
【24h】

Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.

机译:利托那韦熔体挤出物在水性介质中分散后,形成具有改善溶解性能的纳米/微分散体。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of the study was to characterise the aqueous dispersions of ritonavir melt extrudates. More specifically to look into the particular system formed when melt extrudate of a poorly soluble drug dissolved in a hydrophilic polymer matrix containing a surfactant is dispersed in an aqueous medium. Melt extrudates with and without ritonavir were studied. The drug containing extrudate was confirmed to be molecular dispersions of drug in a polymer/surfactant matrix. Particulate dispersions were formed in water from both drug and placebo extrudates. The dispersions were investigated with respect to mean particle size and particle size distribution (photon correlation spectroscopy and optical particle counting), surface charge (zeta potential), particle composition (ultracentrifugation), tendency to form aggregates and precipitate (turbidity), in vitro dissolution rate and drug release. It was concluded that dispersion of melt extrudates in aqueous medium give rise to nano/micro-dispersions. The stability of the nano/micro-dispersion is sensitive to anions and may be subjected to association/aggregation/flocculation as time proceeds after preparation of dispersion. Melt extrudate showed improved dissolution rate and drug release properties compared to crystalline raw material. From studies of single components and physical mixtures of the formulation composition it can be concluded that the drug delivery system itself, namely solid dispersion prepared by melt extrusion technology, plays a key role for the formation of the observed particles.
机译:该研究的目的是表征利托那韦熔融挤出物的水分散体。更具体地说,研究当溶解在含有表面活性剂的亲水聚合物基质中的难溶性药物的熔融挤出物分散在水性介质中时形成的特定系统。研究了有或没有利托那韦的熔融挤出物。证实含有药物的挤出物是药物在聚合物/表面活性剂基质中的分子分散体。药物和安慰剂挤出物在水中形成微粒分散体。研究了分散体的平均粒径和粒径分布(光子相关光谱法和光学粒子计数),表面电荷(ζ电位),颗粒组成(超速离心),形成聚集体和沉淀的趋势(浊度),体外溶解度率和药物释放。结论是,熔融挤出物在水性介质中的分散产生了纳米/微分散。纳米/微分散体的稳定性对阴离子敏感,并且在制备分散体后随着时间的流逝可以进行缔合/聚集/絮凝。与结晶原料相比,熔体挤出物显示出更高的溶解速率和药物释放性能。从制剂组合物的单一组分和物理混合物的研究可以得出结论,药物输送系统本身,即通过熔融挤出技术制备的固体分散体,对于形成观察到的颗粒起着关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号